Moderna
MRNA
#1078
Rank
A$31.86 B
Marketcap
A$80.31
Share price
2.52%
Change (1 day)
100.16%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$31.86 Billion

As of June 2026 Moderna has a market cap of A$31.86 Billion. This makes Moderna the world's 1078th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026A$31.86 B75.09%
2025A$18.20 B-26.69%
2024A$24.82 B-55.39%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Jun 16th, 2026 the market cap of Moderna was reported to be:

A$31.08 Billion
by Nasdaq info icon info icon
A$31.08 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$794.60 B 2,393.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$410.59 B 1,188.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$402.59 B 1,163.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
A$0.79 B-97.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
A$4.21 B-86.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
A$1.17 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$53.59 B 68.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$15.80 B-50.42%๐Ÿ‡บ๐Ÿ‡ธ USA